Metagenomi Therapeutics Inc (MGX)

May 23, 2026

MGX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineQuarterly Earnings Report - Newser

May 23, 2026

May 22, 2026

MGX Q1 2026 Earnings: Missed Expectations as Pre-Revenue Biotech Advances Gene Editing PipelineEarnings Cycle Outlook - Newser

May 22, 2026

May 17, 2026

PRN_FinancialWrapper - FinancialContent

May 17, 2026

May 16, 2026

Number of shareholders of Metagenomi Therapeutics, Inc. – NASDAQ:MGX - TradingView

May 16, 2026

May 15, 2026

Metagenomi Therapeutics (MGX) price target decreased by 10.71% to 8.50 - MSN

May 15, 2026

May 14, 2026

Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance

May 14, 2026

May 14, 2026

Analysts Have Lowered Expectations For Metagenomi Therapeutics, Inc. (NASDAQ:MGX) After Its Latest Results - simplywall.st

May 14, 2026

May 12, 2026

Metagenomi Therapeutics (MGX) reports Q1 loss, misses revenue estimates - MSN

May 12, 2026

May 11, 2026

Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

MSN Money - MSN

May 11, 2026

May 11, 2026

Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy - TipRanks

May 11, 2026

May 11, 2026

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - The Manila Times

May 11, 2026

May 11, 2026

Metagenomi Therapeutics: Q1 Earnings Snapshot - KVUE

May 11, 2026

May 11, 2026

Metagenomi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 11, 2026

May 11, 2026

[10-Q] Metagenomi Therapeutics, Inc. Quarterly Earnings Report - Stock Titan

May 11, 2026

May 11, 2026

Metagenomi (NASDAQ: MGX) details Q1 2026 loss, cash runway and MGX-001 IND plans - Stock Titan

May 11, 2026

May 11, 2026

Metagenomi gene edit for hemophilia A targets 2027 human trials - Stock Titan

May 11, 2026

May 08, 2026

MGX Stock Price, Quote & Chart | METAGENOMI THERAPEUTICS INC (NASDAQ:MGX) - ChartMill

May 08, 2026

May 05, 2026

Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

May 05, 2026

Apr 27, 2026

SEC Form DEF 14A filed by Metagenomi Therapeutics Inc. - Quantisnow

Apr 27, 2026

Apr 27, 2026

[DEF 14A] Metagenomi Therapeutics, Inc. Definitive Proxy Statement - Stock Titan

Apr 27, 2026

Apr 27, 2026

MGX Price Today: Metagenomi Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 27, 2026

Apr 22, 2026

Metagenomi Therapeutics (MGX) Stock: Sentiment Analysis (Weakens) 2026-04-22Large Cap Trends - Xã Thanh Hà

Apr 22, 2026

Apr 21, 2026

MGX Financials: Income Statement, Balance Sheet & Cash Flow | Metagenomi Therapeutics, Inc - Stock Titan

Apr 21, 2026

Apr 16, 2026

A smaller gene editor cut Atxn2 protein 64% in mice, Metagenomi says - Stock Titan

Apr 16, 2026

Apr 16, 2026

Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Eastern Progress

Apr 16, 2026

Apr 16, 2026

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency - The Manila Times

Apr 16, 2026

Apr 13, 2026

What is the valuation of Metagenomi Therapeutics (MGX) Stock | Price at $1.39, Up 0.72%Expert Market Insights - Newser

Apr 13, 2026

Apr 03, 2026

[Form 4] Metagenomi Therapeutics, Inc. Insider Trading Activity - Stock Titan

Apr 03, 2026

Apr 02, 2026

MGX: Metagenomi Therapeutics, Inc.Detailed Earnings Estimates - Zacks Investment Research

Apr 02, 2026

Mar 25, 2026

Metagenomi Can’t Ax IPO Investor Suit Over Moderna Partnership - Bloomberg Law News

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Metagenomi Therapeutics, Inc (MGX) - Stock Titan

Mar 22, 2026

Mar 06, 2026

Metagenomi Therapeutics Fiscal Results: Q4 Loss of $22.5M, Annual Loss $87.9MNews and Statistics - IndexBox

Mar 06, 2026

Mar 05, 2026

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 05, 2026

Mar 05, 2026

Metagenomi Therapeutics: Q4 Earnings Snapshot - kens5.com

Mar 05, 2026

Mar 05, 2026

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - Bitget

Mar 05, 2026

Mar 05, 2026

Metagenomi Therapeutics Q4 Earnings Assessment - Benzinga

Mar 05, 2026

Feb 28, 2026

MGX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026

Feb 25, 2026

MGX Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 25, 2026

Feb 23, 2026

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - The Manila Times

Feb 23, 2026

Feb 23, 2026

Metagenomi Therapeutics, Inc. CEO Jian Irish to Speak at 46th Annual TD Cowen Healthcare Conference - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Gene-editing firm Metagenomi CEO in TD Cowen fireside chat - Stock Titan

Feb 23, 2026

Feb 22, 2026

MGXMetagenomi Therapeutics, Inc Latest Stock News & Market Updates - Stock Titan

Feb 22, 2026

Feb 12, 2026

Is Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Feb 12, 2026

Feb 09, 2026

Head to Head Analysis: Acusphere (OTCMKTS:ACUS) and Metagenomi (NASDAQ:MGX) - Defense World

Feb 09, 2026

Feb 04, 2026

Xeris Biopharma (NASDAQ:XERS) and Metagenomi (NASDAQ:MGX) Critical Comparison - Defense World

Feb 04, 2026